Indegene · NSE: INDGN · BSE: 544172
Q4 FY25 results · Jan–Mar 2025
Indegene reported revenue from operations of ₹755.60 crore (up 12.3% from Q4 FY24) and net profit of ₹117.60 crore (up 24.1% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 755.60 | 673.00 | +12.3% | 720.40 | +4.9% |
| Other income | 25.60 | 23.20 | +10.3% | 37.70 | −32.1% |
| Total income | 781.20 | 696.20 | +12.2% | 758.10 | +3.0% |
| Profit before tax | 149.30 | 133.50 | +11.8% | 146.30 | +2.1% |
| Net profit for the period | 117.60 | 94.80 | +24.1% | 109.70 | +7.2% |
| EPS, basic (₹) | 4.91 | 4.27 | +14.9% | 4.59 | +7.0% |
| Net margin (%) | 15.6 | 14.1 | 15.2 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 266.70 | 272.50 | −2.1% | 286.70 | −7.0% |
| Other income | 35.20 | 23.10 | +52.4% | 22.30 | +57.8% |
| Total income | 301.90 | 295.60 | +2.1% | 309.00 | −2.3% |
| Profit before tax | 66.40 | 60.40 | +9.9% | 66.10 | +0.5% |
| Net profit for the period | 54.20 | 48.90 | +10.8% | 49.90 | +8.6% |
| EPS, basic (₹) | 2.26 | 2.20 | +2.7% | 2.09 | +8.1% |
| Net margin (%) | 20.3 | 17.9 | 17.4 |
Consolidated
- Filed with BSE
- 28 Apr 2025, 20:14 IST
- Board meeting
- 28 Apr 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 28 Apr 2025, 20:14 IST
- Board meeting
- 28 Apr 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE